On-demand education
Special series: Ms. Moreno-Fontela and Assoc. Prof. Kasivisvanathan discuss the significant transition after residency
Prof. James Catto (GB) shares results of THOR-2 cohort 1 study
Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mg
Prof. Roberto Iacovelli: Drug interruptions in mRCC IO-TKI (Avelumab and axitinib) is safe and may reduce toxicity and cost for the treatment
Prof. Albiges shares LITESPARK-005 study results: Belzutifan improves PFS in pretreated mRCC patients
ESMO 2023 special: Dr. Van Der Heijden talks about the phase 3 CheckMate 901 trial results
ESMO 2023 special: Prof. Powles shares positive KEYNOTE-A39 trial results
Special series: Artificial intelligence application for urologic cancer detection and classification
Special series: 3D models for kidney cancer with caval thrombous
Dr. Marra talks to Prof. Ahmed on focal therapy for low- or intermediate-risk PCa
Special series: Vascular perfusion 3D models and augmented reality for RCC surgery
Discussion with Prof. Badani at ERUS23 on RAPN
Special series: 3D models and augmented reality for prostate cancer surgery
Laparoscopic v's new robotic platforms: Which surgery for which intervention?
New technology for surgical training